RecruitingNot applicableNCT07528547
Hypersight and Ethos In Pediatric Radiotherapy
Studying Periodontal Ehlers-Danlos syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Health Network, Toronto
- Intervention
- HyperSight CBCT scans(device)
- Enrollment
- 20 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07528547 on ClinicalTrials.govOther trials for Periodontal Ehlers-Danlos syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT06590402Anterior Femoral and Adductor Canal Nerve Blocks in Peds KneesHospital for Special Surgery, New York
- RECRUITINGPHASE3NCT06739122A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Eli Lilly and Company
- RECRUITINGPHASE3NCT05261139EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseasePfizer
- RECRUITINGPHASE4NCT04040452Continuous vs Intermittent Ketorolac for Pain Control in Peds CV SurgeryPhoenix Children's Hospital